Improvement of Oxidative Stress and Mitochondrial Dysfunction by β-Caryophyllene: A Focus on the Nervous System

Hammad Ullah1, Alessandro Di Minno1,2, Cristina Santarcangelo1

  • 1Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.

Insights

Beta-caryophyllene, a natural compound, shows promise in combating oxidative stress and mitochondrial dysfunction. This may offer neuroprotection against neurodegenerative disorders by stabilizing mitochondria.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Mitochondrial dysfunction, characterized by impaired energy production and increased oxidative stress, is a key factor in neurodegenerative diseases.
  • Neurons are particularly vulnerable to mitochondrial dysfunction due to their high energy demands.
  • Current treatments for neurodegenerative disorders are limited, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

  • To review the potential of beta-caryophyllene as a therapeutic agent for neurodegenerative disorders.
  • To explore the mechanisms by which beta-caryophyllene may counteract oxidative stress and mitochondrial dysfunction.
  • To assess the neuroprotective effects of beta-caryophyllene.

Main Methods:

  • Literature review of studies on beta-caryophyllene, mitochondrial dysfunction, oxidative stress, and neurodegeneration.
  • Analysis of pharmacological activities of beta-caryophyllene, including its antioxidant and anti-inflammatory properties.
  • Examination of beta-caryophyllene's interaction with the cannabinoid receptor 2 (CB2).

Main Results:

  • Beta-caryophyllene exhibits significant antioxidant and anti-inflammatory activities.
  • As a selective CB2 agonist, beta-caryophyllene may modulate cellular responses to oxidative stress.
  • Evidence suggests beta-caryophyllene can mitigate mitochondrial dysfunction and protect against neuronal damage.

Conclusions:

  • Beta-caryophyllene demonstrates considerable potential for neuroprotection by addressing oxidative stress and mitochondrial dysfunction.
  • Its pharmacological properties make it a promising candidate for the development of novel therapies for neurodegenerative diseases.
  • Further research is warranted to fully elucidate the therapeutic applications of beta-caryophyllene in neuroprotection.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
16.5K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
17.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
288